A Cost Effectiveness Analysis Of Single Use And Reuse Dialyser Utilization In Hemodialysis Services For Kidney Failure Patients At Hospital X Stabat

Maas Lubis, Ermi Girsang, Sri Lestari Ramadhani Nasution

Abstract


The prevalence of Chronic Kidney Disease sufferers globally, including Indonesia, has increased every year. According to the 2018 Basic Health Research data, the prevalence of Chronic Kidney Disease in Indonesia is 0.38% of the population of Indonesia or around 713,783 people. The Indonesian Nephrology Association said that the use of reuse dialyzers is permitted with a maximum limit of 7 times of use, Indonesian 2 Renal Registry data shows that reuse dialyzers are mostly used with a frequency of 1-5 times. Manual cleaning of single-use and reuse dialyzers can have an impact on several aspects, including: dialysis adequacy and risk of infection. Putri Bidadari Hospital, Stabat has a problem with changing the reuse dialyzer to single use because if you use reuse, the used equipment is washed again. So by switching to single use, it is hoped that the output of hemodialysis will be better. However, by switching to single use, there is a possibility of additional/reduced costs per patient for each hemodialysis. This study aims to analyze the Cost Effectiveness of Using Single Use and Reuse Dialyzers for Hemodialysis Services for Kidney Failure Patients at Putri Bidadari General Hospital, a cross-sectional quantitative research design with a prospective and retrospective approach, involving 160 patients in 2023. Data were analyzed using Cost Effectiveness Analysis (CEA). The results of the analysis show that the cost efficiency of the Reuse dialyzer is proven to be lower than the Single Use dialyzer. While in producing changes in the outcome of creatinine, urea, and hemoglobin, the single use dialyzer is more effective than the reuse dialyzer. Hospitals also need to conduct an evaluation of the environmental impact of using both types of dialyzers, including medical waste and energy consumption.

Keywords


dialyzer; chronic renal failure; hemodialysis; pharmacoeconomics

References


Hartati, Sri. 2016. Characteristics of Chronic Kidney Failure Patients Undergoing Hemodialysis at Dr. Moewardi Regional General Hospital. Surakarta: Faculty of Health Sciences, Muhammadiyah University of Surakarta.

Indonesian Nephrology Association (Pernefri). Dialysis Implementation Guidelines. Pernefri Dialysis Consensus 2003: 25-52

Malyszko, J., Milkowski, A., Benedyk-Lorens, E., & Dryl-Rydzynska, T. 2016. Effects of dialyzer reuse on dialysis adequacy, anemia control, erythropoieting-stimulating agents use and phosphate levels. Archives of Medical Science, 12(1), 219–221.

Health Research and Development Agency. (2013). Basic Health Research (RISKESDAS) 2013. National Report 2013, 1–384.https://doi.org/1 December 2013

National Kidney Foundation. (2015). KDOQI Clinical Practice Guideline Hemodialysis Update Update of the KDOQI TM Clinical Practice Guideline for Hemodialysis Adequacy. In National Kidney Foundation. https://doi.org/10.1053/j.ajkd.2015.07.015

Chuang FR, Lee CH, Chang HW, Lee CN, Chen TC, Chuang CH, et al. A Quality and Cost-Benefit Analysis of Dialyzer Reuse in Hemodialysis Patients. Renal Failure 2008; 30: 521-526.

Lankhorst, CE, Wish, JB 2010. Anemia in renal disease: diagnosis and management, Blood Rev 24 (1): 39-47.

Indonesian Renal Registry. (2017). 10th Report of the Indonesian Renal Registry. Indonesian Renal Registry (IRR) Program, 1–40.

Smeltzer, S. C., & Bare, B. G. (2020). Brunner & Suddarth's Textbook of Medical-Surgical Nursing. Philadelphia: Wolters Kluwer Health.

O'callaghan, C. 2009. At a Glance: Renal System Second Edition. Jakarta: Erlangga.

Al-Radeef, MY, Ismail, SH, & Allawi, AA-MD 2016. Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis. International Journal of Science and Research, 5(9), 1020–1027.

Beiber, SD and Himmerfarb, J. 2013. Hemodialysis. In: Schriers's Disease of the kidney. 9th ed. Coffman, TM, Falk, RJ, Molitoris, BA, Neilson, EC, Schrier, RW editors. Lipincott Williams & Wittkins. Philadelphia p 2473- 505.

Okazaki, M., Komatsu, M., Kawaguchi, H., Tsuchiya, K., & Nitta, K. 2014. Erythropoietin resistance index and the all-cause mortality of chronic hemodialysis patients. Blood Purification, 37(2), 106–112.


Full Text: PDF

DOI: 10.33751/jhss.v4i3.11222

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.